Casi Pharmaceuticals China

Casi Pharmaceuticals China is owned by Casi Pharmaceuticals.

Casi Pharmaceuticals is a company listed under the stock ticker CASI (US).

Casi Pharmaceuticals has a direct presence in 2 countries.

They are in:

• Pharmaceuticals67%
• Biotechnology33%

View the org chart displaying its 6 main executives

Most searched biographies at Casi Pharmaceuticals China

• Larry Zhang, President
• Alexander Zukiwski, Executive Vice President and Chief Medical Off...
• Michael Wu, Regulatory Director

Create your alert
to follow the executive moves at Casi Pharmaceuticals China.

Casi Pharmaceuticals has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Casi Pharmaceuticals China

Social media about Casi Pharmaceuticals China

• Casi Pharmaceuticals China on Wikipedia, Google News & Yahoo Finance
• Casi Pharmaceuticals China on LinkedIn, Twitter & YouTube

Call Casi Pharmaceuticals China at +86 106...

View the org chart

Register to receive your alert

Report an error